A day in the life of InnoSer neurology study associate Teun van Nunen

A day in the life of InnoSer neurology study associate Teun van Nunen

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

The CONNECT project aims to develop a novel organoid-chip connecting the blood vasculature to the brain to mimic the blood-brain barrier (BBB). This complex 3D-model can be used to mimic aspects of drug delivery into the human brain, a key process that is often not...
Nano+ Project Ends With Promising Results

Nano+ Project Ends With Promising Results

Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
BlastomaBrain: New in vitro platform for oncology drug development

BlastomaBrain: New in vitro platform for oncology drug development

One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...